Company news
Little Green Pharma Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Share Purchase Plan offer extended to 16 January 2023
December 18, 2022
Second exclusive supply agreement with Cannamedical
December 1, 2022
Ethics approval for CBD Phase III clinical trial
November 29, 2022
LGP significantly expands flower portfolio
November 23, 2022
Prospectus
November 20, 2022
Share Purchase Plan open to eligible shareholders
November 20, 2022
Update Four 20 Pharma and French trial extension
November 20, 2022
LGP announces $4 million placement and $2 million SPP
November 1, 2022
Exclusive supply agreement with Cannamedical in Germany
October 3, 2022
TGA advertising infringement notices
September 27, 2022
Quarterly Activities Report & Appendix 4C
July 26, 2022
Application for quotation of securities - LGP
July 20, 2022
LGP signs $2M supply agreement with Ilios Sante
July 11, 2022
Company Update Presentation
June 5, 2022
Exclusive supply contract for new high-THC strain in Germany
May 18, 2022
LGP Signs Key UK Supply Agreement
May 1, 2022
LGP Denmark Signs Major Sales Agreement with Demecan
April 18, 2022
LGP Wins Italian Tender
February 17, 2022
Intention to Demerge Psychedelics Business
February 7, 2022
Exclusive Distribution Agreement for LGP Medicines in Greece
January 20, 2022
Exclusive Cannabis Oils Distribution Agreement in Germany
January 18, 2022
First Registration for Produced Cannabis Medicine in Denmark
November 22, 2021
LGP expands into Psychedelic Medicines
September 6, 2021
First Danish Shipment to Australia, Key Appointments
September 5, 2021
LGP acquires Denmark facility and undertakes share placement
June 22, 2021
Investor Presentation - Denmark acquisition & capital raise
June 22, 2021
Exclusive distribution partner - leading Polish pharma group
June 17, 2021
Update to Sales and Distribution in Australia and Germany
June 14, 2021
$2.5m firm order increases expected DEMECAN revenue to $5.7m
May 26, 2021
LGP agrees Danish Distribution Agreement with Balancial
April 19, 2021
Firm purchase order from Demecan and acquisition of land
March 14, 2021
Share Purchase Plan Offer Booklet
February 14, 2021
LGP secures firm commitments to raise $22 million
February 8, 2021
LGP exports first commercial shipment to Germany
February 5, 2021
LGP wins French government tender
January 26, 2021
TGA announces final CBD down-scheduling decision
December 15, 2020
First Australian Medicinal Cannabis Oils Exported to Germany
November 18, 2020
LGP enters strategic partnership with HIF
November 10, 2020
Pause in Trading
November 9, 2020
Little Green Pharma granted GMP Licence
October 13, 2020
TGA Medicinal Cannabis Post Market Survey
September 22, 2020
Annual Report to shareholders
August 31, 2020
Medicinal Cannabis Permit Granted for Expanded Facility
July 19, 2020
Strategic Shipment Exported to the UK
June 28, 2020
Sales Update - April 2020
May 27, 2020
Clarification Statement
May 13, 2020
ODC Manufacturing Permit Granted
May 10, 2020
Investor Presentation
April 29, 2020
First UK Shipment of Australian Medicinal Cannabis Oil
April 14, 2020
COVID-19 Business Update
April 1, 2020
Decks
The 5 newest of 24 decks. Every deck is listed under its year.
- Investor Presentation (July 2026)
Investor deck · 10 slides · July 2026
- Q3 FY2026 Earnings Presentation
Earnings · 17 slides · May 12, 2026
- Merger or Acquisition (February 2026)
Merger or acquisition · 19 slides · Feb 3, 2026
- Q1 FY2026 Earnings Presentation
Earnings · 20 slides · Nov 12, 2025
- Shareholder Meeting (August 2025)
Shareholder meeting · 13 slides · August 2025